TD Cowen lowered the firm’s price target on Bath & Body Works to $35 from $52 and keeps an Outperform rating on the shares. The firm said macro challenges and category normalization in candles and sanitizers will pressure topline growth in the near-term, but they remain encouraged by compelling innovation personalization efforts via its loyalty program and category expansion.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BBWI:
- Bath & Body Works price target lowered to $42 from $52 at Telsey Advisory
- Bath & Body Works price target lowered to $30 from $40 at Evercore ISI
- Bath & Body Works price target lowered to $35 from $40 at Wells Fargo
- Bath & Body Works price target lowered to $40 from $50 at Baird
- Bath & Body Works price target lowered to $40 from $50 at BofA